IVOI - A Sub $.001 Stock Poised For A Rally

These sub $.001 stocks have been seeing tremendous interest as of late.  One such stock that has yet to see any fanfare is IVOI - iVoice, Inc.  This SEC reporting, transparent sub $.001 stock has been trading in a narrow .0001 - .0002 range for the last several months.  Over this same time it has recieved very little investor interest, even though they are working hard to reduce their debt.

Just this past December they renegotiated a loan with one of their convertible debt holders.  This is a positive step for the company and shareholders.  iVoice, Inc boasts assets of $2.9 million and has spun, over the years, many of its assets off by distributing special dividends to its shareholders.  One such stock you might recall, that recently went parabolic, is TPHM, Thomas Pharmaceuticals, Ltd.  The company has also spun off TYRIA, and IVOT which I believe is now BGNN.  My point is that there is value in IVOI, be it in the common equity, or the chance to own a stake in their next big spin off. 

Aside from the true value of the stock, and the story behind the company, is the nature of the penny stock market.  Currently every sub $.001 stock has been catching a bid.  IVOI seems like a stock that has been left behind.  It has sat quietly in a tight range while non-reporting, assetless stocks run unabated.   I believe IVOI is the next of these stocks to run unabated.


IVOI, with continued buying pressure, could mount a significant rally from current prices.  Factor in some market maker shenanigans and you are looking at a stock that could see $.0008 short term.  With the company set on reducing debt, and a stock that has traded quietly the last year out of the limelight, the ingredients are there for an explosive move higher. 


Keep IVOI on your radar the next few weeks.


iVoice Improves Balance Sheet Through $500,000 Debt
Repayment And Settlement Of Outstanding Debt With
Institutional Investor
MATAWAN, N.J.—December 7, 2009--iVoice, Inc. (OTC Bulletin Board: IVOI), a
developer and licensor of proprietary technologies, announced today that it has repaid
approximately $500,000 in convertible debt to an institutional investor.
On November 13, 2009, iVoice, Inc. (“Company”) entered into a Settlement Agreement
dated November 12, 2009 with YA Global Investments, L.P., formerly known as Cornell
Capital Partners, LP (“YA Global”) whereby: in exchange for a $500,000 cash payment
and entering into a non-interest bearing amended and restated debenture with a
principal amount of $671,600, the Company was able to extinguish all other obligations
owed to YA Global including disputed interest on other debentures previously paid-off,
termination of various warrants, and reduction of the collateral securing the remaining
debenture from all of the assets of the Company to only the $370,000 Secured
Convertible Debenture issued by Thomas Pharmaceuticals, Ltd. and held by iVoice,
Inc. Additionally, the Company and YA Global executed a general release effective
through the date of the Settlement Agreement. This transaction leaves a balance of only
$671,600 due to the institutional investor.
Link to 8K:
http://www.sec.gov/Archives/edgar/data/1105064/000118518509001252/0001185185-
09-001252-index.htm
About iVoice, Inc.
iVoice has determined that the best way to create shareholder value, separate and apart
from the operating performance of iVoice, is to implement new business opportunities by
distributing shares of spin-offs to the Company's shareholders. The common stock
distributions are part of a broader strategy relating to the transition of iVoice into a
company focused on the development and licensing of proprietary technologies. We also
continue to search for potential merger candidates with or without compatible technology
and products, which management feels may offer long term growth prospects.
Certain information included in this press release, may contain forward-looking
statements about our current and expected performance trends, growth plans, business
goals and other matters. These statements may be contained in our filings with the
Securities and Exchange Commission, in our press releases, in other written
communications, and in oral statements made by or with the approval of one of our
authorized officers. Information set forth in this press release contains various "forwardlooking
statements" within the meaning of Section 27A of the Securities Act of 1933 and
Section 21E of the Securities Exchange Act of 1934. The Private Securities Litigation
Reform Act of 1995 (the "Act") provides certain "safe harbor" provisions for forwardlooking
statements. The reader is cautioned that such forward-looking statements are
based on information available at the time and/or management's good faith belief with
respect to future events, and are subject to risks and uncertainties that could cause
actual performance or results to differ materially from those expressed in the statements.